Transgene Biotek Limited (BOM:526139)

Transgene Biotek Statistics

Total Valuation

BOM:526139 has a market cap or net worth of INR 184.88 million. The enterprise value is 349.32 million.

Market Cap	184.88M
Enterprise Value	349.32M

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:526139 has 75.77 million shares outstanding. The number of shares has increased by 7.75% in one year.

Current Share Class	75.77M
Shares Outstanding	75.77M
Shares Change (YoY)	+7.75%
Shares Change (QoQ)	+7.47%
Owned by Insiders (%)	33.21%
Owned by Institutions (%)	8.28%
Float	50.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	72.42
PB Ratio	2.01
P/TBV Ratio	6.93
P/FCF Ratio	n/a
P/OCF Ratio	16.40
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-21.51
EV / Sales	136.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-61.04

Financial Position

The company has a current ratio of 0.08, with a Debt / Equity ratio of 1.79.

Current Ratio	0.08
Quick Ratio	0.01
Debt / Equity	1.79
Debt / EBITDA	n/a
Debt / FCF	-28.83
Interest Coverage	-1.38

Financial Efficiency

Return on equity (ROE) is -16.21% and return on invested capital (ROIC) is -2.46%.

Return on Equity (ROE)	-16.21%
Return on Assets (ROA)	-0.43%
Return on Invested Capital (ROIC)	-2.46%
Return on Capital Employed (ROCE)	-0.76%
Weighted Average Cost of Capital (WACC)	5.69%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.77% in the last 52 weeks. The beta is 0.63, so BOM:526139's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-47.77%
50-Day Moving Average	3.06
200-Day Moving Average	3.90
Relative Strength Index (RSI)	33.35
Average Volume (20 Days)	49,071

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:526139 had revenue of INR 2.55 million and -16.24 million in losses. Loss per share was -0.20.

Revenue	2.55M
Gross Profit	2.55M
Operating Income	-9.93M
Pretax Income	-16.24M
Net Income	-16.24M
EBITDA	-8.47M
EBIT	-9.93M
Loss Per Share	-0.20

Balance Sheet

The company has 564,000 in cash and 165.00 million in debt, with a net cash position of -164.44 million or -2.17 per share.

Cash & Cash Equivalents	564,000
Total Debt	165.00M
Net Cash	-164.44M
Net Cash Per Share	-2.17
Equity (Book Value)	92.08M
Book Value Per Share	1.19
Working Capital	-118.56M

Cash Flow

In the last 12 months, operating cash flow was 11.27 million and capital expenditures -17.00 million, giving a free cash flow of -5.72 million.

Operating Cash Flow	11.27M
Capital Expenditures	-17.00M
Free Cash Flow	-5.72M
FCF Per Share	-0.08

Margins

Gross Margin	100.00%
Operating Margin	-389.11%
Pretax Margin	-636.19%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BOM:526139 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.75%
Shareholder Yield	-7.75%
Earnings Yield	-8.79%
FCF Yield	-3.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4